These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22323186)

  • 1. Comparison of high-throughput biophysical methods to identify stabilizing excipients for a model IgG2 monoclonal antibody: conformational stability and kinetic aggregation measurements.
    Cheng W; Joshi SB; He F; Brems DN; He B; Kerwin BA; Volkin DB; Middaugh CR
    J Pharm Sci; 2012 May; 101(5):1701-20. PubMed ID: 22323186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
    Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR
    J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective protocol for the investigation of physicochemical and conformational stability and aggregation kinetics measurements of therapeutic IgG2 monoclonal antibody.
    Aboel Dahab A; El-Hag D
    J Immunol Methods; 2014 Mar; 405():154-66. PubMed ID: 24530566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical characterization and stabilization of the recombinant albumin fusion protein sEphB4-HSA.
    Shi S; Liu J; Joshi SB; Krasnoperov V; Gill P; Middaugh CR; Volkin DB
    J Pharm Sci; 2012 Jun; 101(6):1969-84. PubMed ID: 22411527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excipients differentially influence the conformational stability and pretransition dynamics of two IgG1 monoclonal antibodies.
    Thakkar SV; Joshi SB; Jones ME; Sathish HA; Bishop SM; Volkin DB; Middaugh CR
    J Pharm Sci; 2012 Sep; 101(9):3062-77. PubMed ID: 22581714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the relevance of local conformational stability and dynamics to the aggregation propensity of an IgG1 and IgG2 monoclonal antibodies.
    Thakkar SV; Sahni N; Joshi SB; Kerwin BA; He F; Volkin DB; Middaugh CR
    Protein Sci; 2013 Oct; 22(10):1295-305. PubMed ID: 23893936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life.
    Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Volkin DB; Weis DD
    MAbs; 2015; 7(1):84-95. PubMed ID: 25524268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly concentrated monoclonal antibody solutions: direct analysis of physical structure and thermal stability.
    Harn N; Allan C; Oliver C; Middaugh CR
    J Pharm Sci; 2007 Mar; 96(3):532-46. PubMed ID: 17083094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ionic strength and pH on the physical and chemical stability of a monoclonal antibody antigen-binding fragment.
    Wang T; Kumru OS; Yi L; Wang YJ; Zhang J; Kim JH; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2013 Aug; 102(8):2520-37. PubMed ID: 23824562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local dynamics and their alteration by excipients modulate the global conformational stability of an lgG1 monoclonal antibody.
    Thakkar SV; Kim JH; Samra HS; Sathish HA; Bishop SM; Joshi SB; Volkin DB; Middaugh CR
    J Pharm Sci; 2012 Dec; 101(12):4444-57. PubMed ID: 23060088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational implications of an inversed pH-dependent antibody aggregation.
    Perico N; Purtell J; Dillon TM; Ricci MS
    J Pharm Sci; 2009 Sep; 98(9):3031-42. PubMed ID: 18803243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High throughput thermostability screening of monoclonal antibody formulations.
    He F; Hogan S; Latypov RF; Narhi LO; Razinkov VI
    J Pharm Sci; 2010 Apr; 99(4):1707-20. PubMed ID: 19780136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pH and light on aggregation and conformation of an IgG1 mAb.
    Mason BD; Schöneich C; Kerwin BA
    Mol Pharm; 2012 Apr; 9(4):774-90. PubMed ID: 22300012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of solvent environment on the conformation and stability of human polyclonal IgG in solution.
    Szenczi A; Kardos J; Medgyesi GA; Závodszky P
    Biologicals; 2006 Mar; 34(1):5-14. PubMed ID: 16168667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational and Colloidal Stabilities of Isolated Constant Domains of Human Immunoglobulin G and Their Impact on Antibody Aggregation under Acidic Conditions.
    Yageta S; Lauer TM; Trout BL; Honda S
    Mol Pharm; 2015 May; 12(5):1443-55. PubMed ID: 25871775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid-induced aggregation of human monoclonal IgG1 and IgG2: molecular mechanism and the effect of solution composition.
    Hari SB; Lau H; Razinkov VI; Chen S; Latypov RF
    Biochemistry; 2010 Nov; 49(43):9328-38. PubMed ID: 20843079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 receptor (IL-1R) liquid formulation development using differential scanning calorimetry.
    Remmele RL; Nightlinger NS; Srinivasan S; Gombotz WR
    Pharm Res; 1998 Feb; 15(2):200-8. PubMed ID: 9523304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acid exposure on the conformation, stability, and aggregation of monoclonal antibodies.
    Ejima D; Tsumoto K; Fukada H; Yumioka R; Nagase K; Arakawa T; Philo JS
    Proteins; 2007 Mar; 66(4):954-62. PubMed ID: 17154421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput assessment of antigen conformational stability by ultraviolet absorption spectroscopy and its application to excipient screening.
    Dasnoy S; Le Bras V; Préat V; Lemoine D
    Biotechnol Bioeng; 2012 Feb; 109(2):502-16. PubMed ID: 21928339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggregation and pH-temperature phase behavior for aggregates of an IgG2 antibody.
    Sahin E; Weiss WF; Kroetsch AM; King KR; Kessler RK; Das TK; Roberts CJ
    J Pharm Sci; 2012 May; 101(5):1678-87. PubMed ID: 22246657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.